Bergmann Anthony 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-03$1.39/sh+2,500$3,475→ 8,223 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-03−2,500→ 0 totalExercise: $1.39Exp: 2025-03-03→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]This option was granted on March 3, 2015 and was previously reported as covering 25,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
- [F2]Shares vested 1/48th on the first day of each month commencing April 1, 2015.